- Home
- QNCX vs THCH Comparison
QNCX vs THCH Comparison
Compare QNCX & THCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- THCH
- Stock Information
- Founded
- QNCX 2012
- THCH 2018
- Country
- QNCX United States
- THCH China
- Employees
- QNCX N/A
- THCH N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- THCH Blank Checks
- Sector
- QNCX Health Care
- THCH Finance
- Exchange
- QNCX Nasdaq
- THCH Nasdaq
- Market Cap
- QNCX 85.9M
- THCH 83.2M
- IPO Year
- QNCX 2019
- THCH N/A
- Fundamental
- Price
- QNCX $1.65
- THCH $2.60
- Analyst Decision
- QNCX Strong Buy
- THCH
- Analyst Count
- QNCX 6
- THCH 0
- Target Price
- QNCX $8.00
- THCH N/A
- AVG Volume (30 Days)
- QNCX 263.4K
- THCH 15.6K
- Earning Date
- QNCX 11-12-2025
- THCH 11-11-2025
- Dividend Yield
- QNCX N/A
- THCH N/A
- EPS Growth
- QNCX N/A
- THCH N/A
- EPS
- QNCX N/A
- THCH N/A
- Revenue
- QNCX N/A
- THCH $187,316,342.00
- Revenue This Year
- QNCX N/A
- THCH N/A
- Revenue Next Year
- QNCX N/A
- THCH N/A
- P/E Ratio
- QNCX N/A
- THCH N/A
- Revenue Growth
- QNCX N/A
- THCH N/A
- 52 Week Low
- QNCX $0.69
- THCH $1.95
- 52 Week High
- QNCX $2.45
- THCH $5.15
- Technical
- Relative Strength Index (RSI)
- QNCX 56.09
- THCH 49.03
- Support Level
- QNCX $1.59
- THCH $2.57
- Resistance Level
- QNCX $1.68
- THCH $2.74
- Average True Range (ATR)
- QNCX 0.06
- THCH 0.09
- MACD
- QNCX 0.01
- THCH 0.01
- Stochastic Oscillator
- QNCX 69.57
- THCH 40.00
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under single reportable segment, Tim Hortons. The company's revenue is derived from its operations in the PRC.